trimethyloxamine has been researched along with Coronary Disease in 16 studies
trimethyloxamine: used in manufacture of quaternary ammonium cpds; insect attractant; warming agent for gas; oxidant; structure
trimethylamine N-oxide : A tertiary amine oxide resulting from the oxidation of the amino group of trimethylamine.
Coronary Disease: An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Riboflavin is a cofactor in TMAO synthesis." | 5.56 | Circulating trimethyllysine and risk of acute myocardial infarction in patients with suspected stable coronary heart disease. ( Berge, RK; Bjørnestad, EØ; Dhar, I; Løland, K; Nilsen, DWT; Nordrehaug, JE; Nygaard, E; Nygård, O; Olset, H; Pedersen, EKR; Svardal, A; Svingen, GFT; Tell, GS; Ueland, PM, 2020) |
| "Atherosclerotic coronary heart disease is a common cardiovascular disease with high morbidity and mortality." | 3.01 | Intestinal Flora Metabolite Trimethylamine Oxide Is Inextricably Linked to Coronary Heart Disease. ( Hu, H; Jing, L; Tian, H; Xiang, Q; Zhai, C; Zhang, H, 2023) |
| "Meta-analysis and dose-response analysis of hazard ratio data from prospective observational studies reporting on the association between TMAO plasma concentrations and the incidence of MACE in patients with CHD were conducted." | 2.66 | Trimethylamine-N-oxide has prognostic value in coronary heart disease: a meta-analysis and dose-response analysis. ( Liao, PD; Wang, L; Yao, ME; Zhao, XJ, 2020) |
| "Riboflavin is a cofactor in TMAO synthesis." | 1.56 | Circulating trimethyllysine and risk of acute myocardial infarction in patients with suspected stable coronary heart disease. ( Berge, RK; Bjørnestad, EØ; Dhar, I; Løland, K; Nilsen, DWT; Nordrehaug, JE; Nygaard, E; Nygård, O; Olset, H; Pedersen, EKR; Svardal, A; Svingen, GFT; Tell, GS; Ueland, PM, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (31.25) | 24.3611 |
| 2020's | 11 (68.75) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, Y | 1 |
| Zheng, G | 1 |
| Jin, X | 1 |
| Fan, T | 1 |
| Chen, Z | 1 |
| Sheng, X | 1 |
| Zhou, P | 1 |
| Zhao, XN | 1 |
| Ma, YY | 1 |
| Tang, TJ | 1 |
| Wang, SS | 1 |
| Wang, L | 2 |
| Huang, JL | 1 |
| Zhang, H | 1 |
| Jing, L | 1 |
| Zhai, C | 1 |
| Xiang, Q | 1 |
| Tian, H | 1 |
| Hu, H | 1 |
| Yao, ME | 1 |
| Liao, PD | 1 |
| Zhao, XJ | 1 |
| Heidenreich, PA | 1 |
| Mamic, P | 1 |
| Heianza, Y | 1 |
| Ma, W | 1 |
| DiDonato, JA | 1 |
| Sun, Q | 2 |
| Rimm, EB | 2 |
| Hu, FB | 2 |
| Rexrode, KM | 1 |
| Manson, JE | 1 |
| Qi, L | 1 |
| Bjørnestad, EØ | 1 |
| Olset, H | 1 |
| Dhar, I | 1 |
| Løland, K | 1 |
| Pedersen, EKR | 1 |
| Svingen, GFT | 1 |
| Svardal, A | 1 |
| Berge, RK | 1 |
| Ueland, PM | 1 |
| Tell, GS | 1 |
| Nilsen, DWT | 1 |
| Nordrehaug, JE | 1 |
| Nygaard, E | 1 |
| Nygård, O | 1 |
| Patanè, S | 1 |
| Rodelo-Haad, C | 1 |
| Pendon-Ruiz de Mier, MV | 1 |
| Soriano, S | 1 |
| Rodríguez, M | 1 |
| Santamaria, R | 1 |
| Amrein, ML | 1 |
| Lopez-Ayala, P | 1 |
| Walter, J | 1 |
| Widmer, V | 1 |
| Mueller, C | 1 |
| Liu, G | 1 |
| Li, J | 1 |
| Li, Y | 1 |
| Hu, Y | 1 |
| Franke, AA | 1 |
| Liang, L | 1 |
| Chan, AT | 1 |
| Mukamal, KJ | 1 |
| Dong, Z | 1 |
| Liang, Z | 1 |
| Guo, M | 1 |
| Hu, S | 1 |
| Shen, Z | 1 |
| Hai, X | 1 |
| Kehrmann, J | 1 |
| Menzel, J | 1 |
| Saeedghalati, M | 1 |
| Obeid, R | 1 |
| Schulze, C | 1 |
| Holzendorf, V | 1 |
| Farahpour, F | 1 |
| Reinsch, N | 1 |
| Klein-Hitpass, L | 1 |
| Streeck, H | 1 |
| Hoffmann, D | 1 |
| Buer, J | 1 |
| Esser, S | 1 |
| Yu, D | 1 |
| Shu, XO | 1 |
| Rivera, ES | 1 |
| Zhang, X | 1 |
| Cai, Q | 1 |
| Calcutt, MW | 1 |
| Xiang, YB | 1 |
| Li, H | 1 |
| Gao, YT | 1 |
| Wang, TJ | 1 |
| Zheng, W | 1 |
| Mueller, DM | 1 |
| Allenspach, M | 1 |
| Othman, A | 1 |
| Saely, CH | 1 |
| Muendlein, A | 1 |
| Vonbank, A | 1 |
| Drexel, H | 1 |
| von Eckardstein, A | 1 |
| Knudsen, A | 1 |
| Christensen, TE | 1 |
| Thorsteinsson, K | 1 |
| Ghotbi, AA | 1 |
| Hasbak, P | 1 |
| Lebech, AM | 1 |
| Nielsen, SD | 1 |
| Hov, JR | 1 |
| Berge, R | 1 |
| Ripa, RS | 1 |
| Kjær, A | 1 |
| Trøseid, M | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Prospective, Epidemiologic and Multicentre Trial to Determine the Cardiovascular Risk, New Cardiovascular Events and the Cardiovascular Diseases in HIV-infected Patients: 15 Year Follow up[NCT04330287] | 2,000 participants (Anticipated) | Observational | 2020-05-11 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 reviews available for trimethyloxamine and Coronary Disease
| Article | Year |
|---|---|
Virtual screening analysis of natural flavonoids as trimethylamine (TMA)-lyase inhibitors for coronary heart disease.
Topics: Coronary Disease; Flavonoids; Hesperidin; Humans; Lyases; Molecular Docking Simulation | 2022 |
Intestinal Flora Metabolite Trimethylamine Oxide Is Inextricably Linked to Coronary Heart Disease.
Topics: Biomarkers; Coronary Disease; Gastrointestinal Microbiome; Humans; Methylamines | 2023 |
Trimethylamine-N-oxide has prognostic value in coronary heart disease: a meta-analysis and dose-response analysis.
Topics: Aged; Aged, 80 and over; Biomarkers; Coronary Disease; Female; Humans; Incidence; Male; Methylamines | 2020 |
13 other studies available for trimethyloxamine and Coronary Disease
| Article | Year |
|---|---|
Influence of Gut Microbiota and Trimethylamine N-Oxide in Patients with Coronary Heart Disease.
Topics: Coronary Disease; Gastrointestinal Microbiome; Humans; Methylamines; Microbiota; Phylogeny | 2022 |
Is Our Diet Turning Our Gut Microbiome Against Us?
Topics: Coronary Disease; Diet; Gastrointestinal Microbiome; Humans; Methylamines | 2020 |
Long-Term Changes in Gut Microbial Metabolite Trimethylamine N-Oxide and Coronary Heart Disease Risk.
Topics: Adult; Case-Control Studies; Coronary Disease; Diet, Healthy; Female; Gastrointestinal Microbiome; H | 2020 |
Circulating trimethyllysine and risk of acute myocardial infarction in patients with suspected stable coronary heart disease.
Topics: Aged; Biomarkers; Coronary Disease; Female; Heart Disease Risk Factors; Humans; Lysine; Male; Methyl | 2020 |
Long-Term Changes in Gut Microbial Metabolite TMAO, CHD Risk, and its Complex Regulatory Network.
Topics: Coronary Disease; Gastrointestinal Microbiome; Humans; Methylamines | 2020 |
Trimethylamine N-Oxide and Coronary Heart Disease: Should We Consider the Kidney Function?
Topics: Coronary Disease; Gastrointestinal Microbiome; Humans; Kidney; Methylamines | 2020 |
Coronary Heart Disease and TMAO Concentrations.
Topics: Coronary Disease; Gastrointestinal Microbiome; Humans; Methylamines | 2020 |
Gut microbiota-derived metabolites and risk of coronary artery disease: a prospective study among US men and women.
Topics: 4-Butyrolactone; Adult; Case-Control Studies; Coronary Disease; Diet; Female; Gastrointestinal Micro | 2021 |
The Association between Plasma Levels of Trimethylamine N-Oxide and the Risk of Coronary Heart Disease in Chinese Patients with or without Type 2 Diabetes Mellitus.
Topics: Aged; China; Coronary Disease; Creatine Kinase, MB Form; Diabetes Mellitus, Type 2; Female; Humans; | 2018 |
Gut Microbiota in Human Immunodeficiency Virus-Infected Individuals Linked to Coronary Heart Disease.
Topics: Adult; Aged; Bacteroides; Biodiversity; Coronary Disease; Female; Gastrointestinal Microbiome; HIV I | 2019 |
Urinary Levels of Trimethylamine-N-Oxide and Incident Coronary Heart Disease: A Prospective Investigation Among Urban Chinese Adults.
Topics: Adult; Aged; Biomarkers; Case-Control Studies; China; Coronary Disease; Female; Follow-Up Studies; H | 2019 |
Plasma levels of trimethylamine-N-oxide are confounded by impaired kidney function and poor metabolic control.
Topics: Aged; Betaine; Biomarkers; Blood Glucose; Choline; Chromatography, Liquid; Coronary Angiography; Cor | 2015 |
Microbiota-Dependent Marker TMAO is Not Associated With Decreased Myocardial Perfusion in Well-Treated HIV-Infected Patients as Assessed by 82Rubidium PET/CT.
Topics: Biomarkers; Cardiovascular System; Coronary Disease; Cross-Sectional Studies; Female; Gastrointestin | 2016 |